Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             324 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A2 adrenergic agonists prevent NMDA antagonist neurotoxicity Farber, N.B.
 1995
 37 9 p. 649-
1 p.
 artikel
2 Abnormal growth of cultured skin fibroblasts from psychotic patients Mukherjee, S.
 1995
 37 9 p. 626-627
2 p.
 artikel
3 Abnormal saccadic eye movements associated with positive family history schizophrenics Schwartz, B.D.
 1995
 37 9 p. 683-
1 p.
 artikel
4 A comparative study of eight high- and eight low-density families of schizophrenia XisLing, L.
 1995
 37 9 p. 641-
1 p.
 artikel
5 A computational model of the effects of locus coeruleus neuromodulatlon on attention Cohen, J.D.
 1995
 37 9 p. 618-
1 p.
 artikel
6 Acute phase proteins in affective illness Hornig-Rohan, M.
 1995
 37 9 p. 607-
1 p.
 artikel
7 Administration of dexamethasone and its effects on sleep and daytime alertness Folkerts, M.
 1995
 37 9 p. 610-611
2 p.
 artikel
8 Adrenergic receptor function in premenstrual dysphoric disorder Gurguis, G.N.M.
 1995
 37 9 p. 607-
1 p.
 artikel
9 Affective disorders after prenatal influenza exposure Brown, A.S.
 1995
 37 9 p. 610-
1 p.
 artikel
10 Aggression in the treatment of inpatients with schizophrenia, using the overt aggression scale Su, T.
 1995
 37 9 p. 668-
1 p.
 artikel
11 Altered 5-HT and NK cell activity in the forced swim test Menolascino, M.P.
 1995
 37 9 p. 605-606
2 p.
 artikel
12 Analgesic efficacy of enadoline, a selective κ-opioid agonist Pande, A.C.
 1995
 37 9 p. 650-
1 p.
 artikel
13 An analysis of factors contributing to polypharmacy Wolf, M.E.
 1995
 37 9 p. 649-
1 p.
 artikel
14 A naturalistic study of methylphenidate in the treatment of negative symptoms in dementias Galynker, I.
 1995
 37 9 p. 651-
1 p.
 artikel
15 An ERP study of the auditory P3A and P3B components in schizophrenia Ohta, H.
 1995
 37 9 p. 630-631
2 p.
 artikel
16 A neural network model of panic disorder Ownby, R.L.
 1995
 37 9 p. 616-
1 p.
 artikel
17 A new marijuana use epidemic: Marked marijuana use increases in annual (1994) survey Gold, M.S.
 1995
 37 9 p. 628-
1 p.
 artikel
18 Antidepressant and glucocorticoid receptor modulation of startle and anxiety responses Beaulieu, S.
 1995
 37 9 p. 622-
1 p.
 artikel
19 Anxiety in unipolar and bipolar depression Salah, R.S.
 1995
 37 9 p. 616-
1 p.
 artikel
20 A preliminary report on the safety and pharmacokinetics of ibogaine Mash, D.C.
 1995
 37 9 p. 652-
1 p.
 artikel
21 A qualitative assessment of perseverative responses of schizophrenia patients Perry, W.
 1995
 37 9 p. 635-
1 p.
 artikel
22 A seasonal and circadian study of suicide over a 10-year period in the Seattle area Avery, D.H.
 1995
 37 9 p. 611-
1 p.
 artikel
23 A serotonin peripheral marker is decreased in children with coeliac disease Marazziti, D.
 1995
 37 9 p. 612-
1 p.
 artikel
24 A simplified routine assay for urinary 3-methoxy-4-hydroxyphenylglycol Yao, J.K.
 1995
 37 9 p. 646-
1 p.
 artikel
25 A SPECT study of depression in Alzheimer's disease Starkstein, S.E.
 1995
 37 9 p. 642-
1 p.
 artikel
26 Asperger's syndrome in later life: Demographics, phenomenology & neuropsychology Mosovich, S.
 1995
 37 9 p. 658-659
2 p.
 artikel
27 Association of CSP with medial temporal structural abnormality Fukuzako, H.
 1995
 37 9 p. 639-
1 p.
 artikel
28 A study of motor asymmetry in schizophrenia and bipolar disorder Lohr, J.B.
 1995
 37 9 p. 627-
1 p.
 artikel
29 A survey of behavioral problems in mentally retarded/developmentally disabled subjects Spadaccini, E.
 1995
 37 9 p. 619-
1 p.
 artikel
30 A survey of body dysmorphic disorder in plastic surgery patients Aronowitz, B.R.
 1995
 37 9 p. 612-
1 p.
 artikel
31 Attentional and behavioral predictors of outcome in adolescent psychiatric inpatients Pogge, D.L.
 1995
 37 9 p. 658-
1 p.
 artikel
32 Attentional dysfunction in schizotypal personality disorder Bergman, A.
 1995
 37 9 p. 645-
1 p.
 artikel
33 Attention, semantic processing, and symptoms in schizophrenia Carter, C.
 1995
 37 9 p. 638-
1 p.
 artikel
34 Atypical neuroleptics and neuropsychological function in schizophrenia Taylor, S.F.
 1995
 37 9 p. 675-
1 p.
 artikel
35 Auditory ERPs in schizophrenia: Diagnostic and symptom correlates Schwarzkopf, S.B.
 1995
 37 9 p. 636-
1 p.
 artikel
36 Auditory processing during speech production in schizophrenia Pardo, J.V.
 1995
 37 9 p. 632-
1 p.
 artikel
37 Autonomic activity in panic disorder and PTSD Gurguis, G.N.M.
 1995
 37 9 p. 616-
1 p.
 artikel
38 Autonomic reactivity in manic and schizophrenic patients Schnur, D.B.
 1995
 37 9 p. 663-
1 p.
 artikel
39 Biological predictors of one-year outcome in schizophrenia Goldman, M.
 1995
 37 9 p. 676-
1 p.
 artikel
40 Biological predictors of suicidality in schizophrenia Lewis, C.
 1995
 37 9 p. 660-
1 p.
 artikel
41 Biopsychosocial differentiation of anxiety and depression in Chinese Ko, H-C.
 1995
 37 9 p. 605-
1 p.
 artikel
42 Body dysmorphic disorder is comorbid with major depression Nierenberg, A.A.
 1995
 37 9 p. 611-
1 p.
 artikel
43 Brain blood flow in post traumatic stress disorder: SPECT activation Liberzon, I.
 1995
 37 9 p. 622-
1 p.
 artikel
44 Brain volume correlated with neuropsychological ability in first episode schizophrenia Bilder, R.M.
 1995
 37 9 p. 625-
1 p.
 artikel
45 Can anabolic steroids be studied in a randomized and blinded design? Yates, W.
 1995
 37 9 p. 605-
1 p.
 artikel
46 Cardiac autonomic function in childhood anxiety disorders Yeragani, V.K.
 1995
 37 9 p. 614-
1 p.
 artikel
47 Cardiac autonomic function in panic disorder: Analysis of 24-hour heart rate time series Yeragani, V.K.
 1995
 37 9 p. 622-623
2 p.
 artikel
48 Cerebral blood flow correlates of emotion in elderly humans Paradiso, S.
 1995
 37 9 p. 660-
1 p.
 artikel
49 Cerebral MRI of human brain development: Ages 4–18 Giedd, J.N.
 1995
 37 9 p. 657-
1 p.
 artikel
50 Changes in EEG resonance following SDZ MAR 327 treatment Jin, Y.
 1995
 37 9 p. 669-
1 p.
 artikel
51 Changes in interleukin levels in CSF and serum of schizophrenic patients Barak, V.
 1995
 37 9 p. 640-
1 p.
 artikel
52 Characterization of the relationship between negative symptoms and cognitive impairment in schizophrenia Lombardi, J.
 1995
 37 9 p. 665-
1 p.
 artikel
53 Childhood-onset schizophrenia: The severity of premorbid course Alaghband-Rad, J.
 1995
 37 9 p. 625-
1 p.
 artikel
54 Children at risk for anxiety disorders Beidel, D.C.
 1995
 37 9 p. 593-
1 p.
 artikel
55 Chlorpromazine and haloperidol effects on DNA damage and repair of actively transcribed genes Sirota, P.
 1995
 37 9 p. 599-
1 p.
 artikel
56 Cholinergic challenge in personality disorders Steinberg, B.
 1995
 37 9 p. 597-
1 p.
 artikel
57 Chronic cocaine-induced tolerance precedes sensitization in rat forebrain Hammer Jr., R.P.
 1995
 37 9 p. 620-
1 p.
 artikel
58 Cingulate and right temporal glucose metabolic rates correlate with impulsive aggression in closed head injury patients Andreason, P.
 1995
 37 9 p. 645-
1 p.
 artikel
59 Clinical correlates of cholinergic hyperactivity in schizophrenia Tandon, R.
 1995
 37 9 p. 678-
1 p.
 artikel
60 Clinical correlates of the deficit syndrome of schizophrenia Florence, T.
 1995
 37 9 p. 677-
1 p.
 artikel
61 Clinical significance of negative symptoms in stroke patients Galynker, I.
 1995
 37 9 p. 672-
1 p.
 artikel
62 CNS oxytocin binding: Effects of stress and glucocorticoids Liberzon, I.
 1995
 37 9 p. 646-
1 p.
 artikel
63 Cocaine, marijuana, alcohol, and violence: Results of annual high school survey Gold, M.S.
 1995
 37 9 p. 627-
1 p.
 artikel
64 Cognitive effects of typical and atypical antipsychotics in schizophrenia Goldman, R.
 1995
 37 9 p. 677-
1 p.
 artikel
65 Cognitive functions in late-life minor depression Moberg, P.J.
 1995
 37 9 p. 606-
1 p.
 artikel
66 Cognitive impairment as predictor of inpatient hospital stay Rosenblum, J.
 1995
 37 9 p. 672-
1 p.
 artikel
67 Combined electroconvulsive therapy and clozapine in schizophrenia Kales, H.
 1995
 37 9 p. 678-
1 p.
 artikel
68 Combined SPECT and quantitative EEG studies in cocaine abusers with concurrent depression or PTSD Konopka, L.M.
 1995
 37 9 p. 628-
1 p.
 artikel
69 Complex demodulation: An effective technique to study cardiac autonomic function Yeragani, V.K.
 1995
 37 9 p. 614-615
2 p.
 artikel
70 Contrasting neuroendocrine responses in depression and chronic fatigue syndrome Cleare, A.J.
 1995
 37 9 p. 655-
1 p.
 artikel
71 Correlations of drug action between human platelet and human brain 5-HTT Rausch, J.
 1995
 37 9 p. 600-
1 p.
 artikel
72 CSF CGRP correlates with neuropeptides in controls but not affective illness George, M.S.
 1995
 37 9 p. 610-
1 p.
 artikel
73 CSF homovanillic acid predicts behavioral response to stimulants in 47 ADHD boys Castellanos, F.X.
 1995
 37 9 p. 644-
1 p.
 artikel
74 CSF neuropeptide Y in mood disorders and treatment with carbamazepine Frye, M.A.
 1995
 37 9 p. 609-610
2 p.
 artikel
75 CSF serotonin: Diagnostic and seasonal differences Brewerton, T.D.
 1995
 37 9 p. 655-
1 p.
 artikel
76 Cytokine regulation of fetal neuronal survival: A role in schizophrenia? Gilmore, J.H.
 1995
 37 9 p. 665-666
2 p.
 artikel
77 D-amphetamine effects on cognition in schizotypal personality Siegel Jr., B.V.
 1995
 37 9 p. 598-
1 p.
 artikel
78 D3 and D4 dopamine receptor expression in the human cortex and striatum Meador-Woodruff, J.H.
 1995
 37 9 p. 647-
1 p.
 artikel
79 Delayed matching to sample in first episode schizophrenia Turkel, E.
 1995
 37 9 p. 666-
1 p.
 artikel
80 Delayed response to antidepressants in depressed patients with comorbid anxiety Russell, J.M.
 1995
 37 9 p. 607-
1 p.
 artikel
81 Detection of hereditary pleomorphy of complement factor 4 in schizophrenia Xiaolin, L.
 1995
 37 9 p. 641-642
2 p.
 artikel
82 Detection of retroviral serum antibodies in schizophrenics Hart, D.J.
 1995
 37 9 p. 664-
1 p.
 artikel
83 Developmental changes in motility and sensory gating: Strain differences Schwarzkopf, S.B.
 1995
 37 9 p. 656-
1 p.
 artikel
84 Development of human anxiety Rosenbaum, J.F.
 1995
 37 9 p. 593-
1 p.
 artikel
85 Differential mood and endocrine effects of intravenous vs. intrathecal TRH Callahan, A.M.
 1995
 37 9 p. 609-
1 p.
 artikel
86 Dopamine receptor gene expression in postmortem brain in schizophrenia Meador-Woodruff, J.H.
 1995
 37 9 p. 653-
1 p.
 artikel
87 Dopamine transporter and receptor autoradiography in cocaine psychosis and sudden death Staley, J.K.
 1995
 37 9 p. 656-657
2 p.
 artikel
88 Dopamine transporter changes in schizophrenia Hitri, A.
 1995
 37 9 p. 653-
1 p.
 artikel
89 Dyadic relationships and the schizophrenic syndromes Cowen, M.A.
 1995
 37 9 p. 662-
1 p.
 artikel
90 Early abuse and biological measures in personality disorder patients Steinberg, B.
 1995
 37 9 p. 658-
1 p.
 artikel
91 Early relationships and resilient outcomes among children of the working poor Constantino, J.N.
 1995
 37 9 p. 614-
1 p.
 artikel
92 ECT may cause redistribution and decrease regional cerebral blood flow Yang, S.
 1995
 37 9 p. 603-
1 p.
 artikel
93 EEG topography of atypical neuroleptics Milstein, V.
 1995
 37 9 p. 679-
1 p.
 artikel
94 Effect of cumulated partial sleep deprivation on TRH test responses Duval, F.
 1995
 37 9 p. 602-
1 p.
 artikel
95 Effect of isoproterenol on cerebral blood flow in healthy humans Cameron, O.
 1995
 37 9 p. 615-616
2 p.
 artikel
96 Effect of MK-212, a centrally acting serotonin agonist, on prolactin, cortisol and body temperature in schizophrenia Ranjan, R.
 1995
 37 9 p. 678-679
2 p.
 artikel
97 Effect of the selective serotonin re-uptake inhibitor fluvoxamine on CCK-4 induced panic attacks van Megen, H.J.G.M.
 1995
 37 9 p. 619-
1 p.
 artikel
98 Effects of acoustic startle on time estimation Fitzpatrick, D.F.
 1995
 37 9 p. 615-
1 p.
 artikel
99 Effects of amphetamine in major depressive disorder using functional MRI Trivedi, M.H.
 1995
 37 9 p. 657-
1 p.
 artikel
100 Effects of a PCP analog on sensory gating: Implications for schizophrenia Al-Amin, H.A.
 1995
 37 9 p. 635-636
2 p.
 artikel
101 Effects of high-dose intravenous TRH on craving and mood state in recently detoxified alcoholic men Garbutt, J.C.
 1995
 37 9 p. 620-
1 p.
 artikel
102 Effects of prior electroconvulsive therapy on seizure induction & duration Mahapatra, S.
 1995
 37 9 p. 624-
1 p.
 artikel
103 Effects of race on EEG sleep in major depression Giles, D.E.
 1995
 37 9 p. 624-
1 p.
 artikel
104 Effects of RU 486 and spironolactone on the HPA axis in normal subjects Duval, F.
 1995
 37 9 p. 602-
1 p.
 artikel
105 Effects of Seroquel® and other atypical antipsychotics in primate models of EPS Goldstein, J.M.
 1995
 37 9 p. 646-647
2 p.
 artikel
106 Efficacy and safety of sertindole in a trial of schizophrenic patients Zborowski, J.
 1995
 37 9 p. 661-662
2 p.
 artikel
107 Efficacy of clinical management vs. drug treatment in depression Malt, U.F.
 1995
 37 9 p. 611-612
2 p.
 artikel
108 Efficacy of clozapine vs. haloperidol in a long-term clinical trial: Preliminary results Ames, D.
 1995
 37 9 p. 661-
1 p.
 artikel
109 Electro-convulsive treatment (ECT) in refractory adolescent depression Ghaziuddin, N.
 1995
 37 9 p. 595-
1 p.
 artikel
110 Elevated concentrations of CSF CGRP might be a trait marker for affective illness Mathé, A.A.
 1995
 37 9 p. 654-
1 p.
 artikel
111 Elevated levels of GABA in young men at high risk for alcoholism Petty, F.
 1995
 37 9 p. 650-
1 p.
 artikel
112 Enhancement of implicit memory in Alzheimer's disease Schwartz, B.L.
 1995
 37 9 p. 596-
1 p.
 artikel
113 Epidemiology of schizophrenia: Gender and age of onset Hwu, H.G.
 1995
 37 9 p. 668-669
2 p.
 artikel
114 Evening TSH response to low doses of TRH in depression Duval, F.
 1995
 37 9 p. 601-602
2 p.
 artikel
115 Event-related potentials in word recognition memory in depressive patients Dietrich, D.E.
 1995
 37 9 p. 604-605
2 p.
 artikel
116 Evidence that GBR12909 attenuates dopaminergic actions of cocaine by binding to dopamine transporter sites in rat brain Baumann, M.H.
 1995
 37 9 p. 656-
1 p.
 artikel
117 Evoked responses in subjects at risk for Alzheimer's disease Boutros, N.N.
 1995
 37 9 p. 596-
1 p.
 artikel
118 Examining serotonin function: A modified technique for rapid tryptophan depletion Krahn, L.E.
 1995
 37 9 p. 659-
1 p.
 artikel
119 Excessive mortality in free-ranging male primates with low CSF 5-HIAA Higley, J.D.
 1995
 37 9 p. 659-
1 p.
 artikel
120 Exonic and intronic polymorphisms in the dopamine D3 gene Crocq, M.A.
 1995
 37 9 p. 663-
1 p.
 artikel
121 Expectancy effects and attentional control in schizophrenia Carter, C.
 1995
 37 9 p. 638-
1 p.
 artikel
122 Expression of mRNA for neurotensin in rat brain cholinergic neurons Nakachi, N.
 1995
 37 9 p. 642-
1 p.
 artikel
123 Eye movement density in REM sleep and delta sleep distribution in depression Sirota, P.
 1995
 37 9 p. 604-
1 p.
 artikel
124 Eye-movement dysfunctions in schizophrenia: State or trait? Obuchowski, M.
 1995
 37 9 p. 670-
1 p.
 artikel
125 Eye tracking dysfunction in offspring from the New York high-risk project Rosenberg, D.
 1995
 37 9 p. 624-625
2 p.
 artikel
126 Facilitation and interference of selective attention in schizophrenia Taylor, S.F.
 1995
 37 9 p. 675-
1 p.
 artikel
127 Factor structure of the neurological evaluation scale Sanders, R.D.
 1995
 37 9 p. 680-
1 p.
 artikel
128 Familial/sporadic schizophrenia: Differences in neuropsychological function Goldman, M.
 1995
 37 9 p. 674-
1 p.
 artikel
129 Famotidine adjunctive pharmacotherapy of schizophrenia Rosse, R.B.
 1995
 37 9 p. 666-
1 p.
 artikel
130 18 F-DOPA PET study of the presynaptic dopamine function in schizophrenia Elkashef, A.
 1995
 37 9 p. 626-
1 p.
 artikel
131 “First night effect” in depression: New data and a new approach Sirota, P.
 1995
 37 9 p. 604-
1 p.
 artikel
132 Fluoxetine and norfluoxetine plasma levels in major depression Amsterdam, J.D.
 1995
 37 9 p. 606-
1 p.
 artikel
133 Fluoxetine effects on monoamines in discrete brain regions Nakamura, M.
 1995
 37 9 p. 648-
1 p.
 artikel
134 Fragile X syndrome Reiss, A.L.
 1995
 37 9 p. 629-
1 p.
 artikel
135 Frequency of pulsatile cortisol and ACTH secretion in depressed patients Deuschle, M.
 1995
 37 9 p. 603-
1 p.
 artikel
136 Frontal and temporal cortex function in schizophrenia during a memory task Hazlett, E.A.
 1995
 37 9 p. 637-
1 p.
 artikel
137 Functional anatomy of selective attention in normals and schizophrenia Carter, C.
 1995
 37 9 p. 638-639
2 p.
 artikel
138 Further support for the “drift” hypothesis of schizophrenia Brar, J.S.
 1995
 37 9 p. 639-
1 p.
 artikel
139 GABA levels in cerebrospinal fluid and plasma during alcohol withdrawal Adinoff, B.
 1995
 37 9 p. 628-
1 p.
 artikel
140 GABA neuroendocrine challenge in normal controls Davis, L.L.
 1995
 37 9 p. 650-
1 p.
 artikel
141 Gender and symptoms, outcome & biological markers in schizophrenia Goldman, M.
 1995
 37 9 p. 677-
1 p.
 artikel
142 Gender differences in cortical metabolism in schizophrenia Siegel Jr., B.V.
 1995
 37 9 p. 671-
1 p.
 artikel
143 Glucose metabolic rate of the basal ganglia in schizophrenia Shihabuddin, L.
 1995
 37 9 p. 637-
1 p.
 artikel
144 Glutamatergic regulation of dopamine receptor mRNA Healy, D.J.
 1995
 37 9 p. 665-
1 p.
 artikel
145 Gray matter deficits in epilepsy with schizophrenia-like symptoms Marsh, L.
 1995
 37 9 p. 631-632
2 p.
 artikel
146 Gray matter deficits in schizophrenia-alcoholism comorbidity Mathalon, D.H.
 1995
 37 9 p. 629-
1 p.
 artikel
147 Haloperidol: Plasma level and dose/clinical response relationship Janicak, P.G.
 1995
 37 9 p. 651-652
2 p.
 artikel
148 Headache responses to M-CPP in OCD and normal controls Wong, C.
 1995
 37 9 p. 615-
1 p.
 artikel
149 Heterogeneity of the psychoses: I. Dopamine psychosis Garver, D.L.
 1995
 37 9 p. 681-682
2 p.
 artikel
150 Heterogeneity of the psychoses: II. Neuro-degenerative psychosis Garver, D.L.
 1995
 37 9 p. 682-
1 p.
 artikel
151 Histones are components of senile plaques in Alzheimer's disease Issidorides, M.R.
 1995
 37 9 p. 643-
1 p.
 artikel
152 HMPAO-SPECT imaging during intense Tibetan Buddhist meditation Newberg, A.
 1995
 37 9 p. 619-
1 p.
 artikel
153 HPA response to ECT as a function of age and basal HPA activity Mourilhe, P.
 1995
 37 9 p. 613-
1 p.
 artikel
154 Human SPECT studies of amphetamine-induced change in dopamine activity Simkowitz, P.
 1995
 37 9 p. 598-
1 p.
 artikel
155 Hypofrontality and working memory dysfunction in schizophrenia Cohen, J.D.
 1995
 37 9 p. 633-
1 p.
 artikel
156 Hypothyroidism reduces threshold for depression by lowering central 5-HT activity Cleare, A.J.
 1995
 37 9 p. 680-681
2 p.
 artikel
157 I-125-LIZAC, a novel ligand binding with high affinity to 5-HT-3 CNS receptors Hewlett, W.A.
 1995
 37 9 p. 668-
1 p.
 artikel
158 Improvement in substance abuse patients medicated for depression Harman, E.
 1995
 37 9 p. 620-
1 p.
 artikel
159 Incidence and correlates of acute extrapyramidal symptoms in first episode schizophrenia Chakos, M.
 1995
 37 9 p. 660-661
2 p.
 artikel
160 Incidence and correlates of TD in first episode schizophrenia Chakos, M.
 1995
 37 9 p. 666-
1 p.
 artikel
161 Increased IGF-1 in patients with major depression Deuschle, M.
 1995
 37 9 p. 603-
1 p.
 artikel
162 Increased IL-1 and IL-3 LR in schizophrenia Sirota, P.
 1995
 37 9 p. 663-
1 p.
 artikel
163 Increased vulnerability to tardive dyskinesia development inschizophrenics with cortical metabolic dysfunction Szymanski, S.
 1995
 37 9 p. 626-
1 p.
 artikel
164 Inhibition of plasma methionine-enkephalin degradation by neuroleptic drugs Mosnaim, A.D.
 1995
 37 9 p. 667-
1 p.
 artikel
165 Inhibition of synthesis of nitric oxide by antidepressants in the brain El-Fakahany, E.E.
 1995
 37 9 p. 649-
1 p.
 artikel
166 Insulin secretion and insulin sensitivity in major depression Weber, B.
 1995
 37 9 p. 603-
1 p.
 artikel
167 Interference with nitric oxide production and action potentiates flurazepam's antiseizure efficacy Deutsch, S.I.
 1995
 37 9 p. 599-
1 p.
 artikel
168 Interrater reliability of the neurological evaluation scale Sanders, R.D.
 1995
 37 9 p. 680-
1 p.
 artikel
169 In vitro effect of lithium carbonate on cerebellar nuclei Sidiropoulou-Skokou, S.
 1995
 37 9 p. 650-651
2 p.
 artikel
170 Ipsapirone as a serotonergic probe in personality disordered patients Falk, J.
 1995
 37 9 p. 598-
1 p.
 artikel
171 Is there arrested development of the corpus callosum in first-break schizophrenic patients? Keshavan, M.S.
 1995
 37 9 p. 653-654
2 p.
 artikel
172 Kainate receptor subunit expression in old-world monkey and human brain Meador-Woodruff, J.H.
 1995
 37 9 p. 665-
1 p.
 artikel
173 Lack of correlations of plasma HVA with psychotic severity in a naturalistic setting Kasckow, J.W.
 1995
 37 9 p. 664-665
2 p.
 artikel
174 Landmark analysis of the neuroanatomy of schizophrenia DeQuardo, J.R.
 1995
 37 9 p. 674-
1 p.
 artikel
175 Learned helplessness: In vivo biogenic amine release in hypothalamus Petty, F.
 1995
 37 9 p. 608-
1 p.
 artikel
176 Lexical priming in schizophrenia: The effects of anti-psychotic medication Cohen, J.D.
 1995
 37 9 p. 632-633
2 p.
 artikel
177 Limbic cortical serotonin 1A receptor mRNA in schizophrenia Bachus, S.E.
 1995
 37 9 p. 682-683
2 p.
 artikel
178 Limitations of FMRI studies of limbic activation Servan-Schreiber, D.
 1995
 37 9 p. 657-
1 p.
 artikel
179 Localization of the functional effects of clonidine by PET Fu, C.
 1995
 37 9 p. 653-
1 p.
 artikel
180 Long-term treatment of anxiety disorders Mavissakalian, M.R.
 1995
 37 9 p. 594-
1 p.
 artikel
181 Mathematical modeling of nocturnal melatonin secretion in depression Rubin, R.T.
 1995
 37 9 p. 648-649
2 p.
 artikel
182 Melatonin affects the processing of β-amyloid precursor protein in cell lines Lahiri, D.K.
 1995
 37 9 p. 595-596
2 p.
 artikel
183 Membrane lipid peroxidation and neurological signs in first episode psychosis Scheffer, R.
 1995
 37 9 p. 681-
1 p.
 artikel
184 Memory deficits in first episode schizophrenia: Beyond impaired acquisition Willson, D.F.
 1995
 37 9 p. 640-641
2 p.
 artikel
185 Metabolic rates in Brodmann areas of Alzheimer's patients Stein, D.J.
 1995
 37 9 p. 642-
1 p.
 artikel
186 Metachromatic leukodystrophy: A clue to alcoholism Manowitz, P.
 1995
 37 9 p. 630-
1 p.
 artikel
187 Midlatency auditory evoked potential habituation in PTSD Gillette, G.M.
 1995
 37 9 p. 617-
1 p.
 artikel
188 Mitogenic response to bFGF and cerebral volume in psychotic patients Mukherjee, S.
 1995
 37 9 p. 681-
1 p.
 artikel
189 Modeling memory-guided tasks in schizophrenia Forman, S.D.
 1995
 37 9 p. 633-
1 p.
 artikel
190 Modulation of serotonin 1A receptor gene expression by antidepressants Lopez, J.F.
 1995
 37 9 p. 599-600
2 p.
 artikel
191 Monoaminergic correlates of temperament in PTSD patients Crayton, J.W.
 1995
 37 9 p. 616-617
2 p.
 artikel
192 Morphometric changes in prefrontal cortex of schizophrenic postmortem brain Rajkowska, G.
 1995
 37 9 p. 667-
1 p.
 artikel
193 Motor performance in schizophrenia: Treatment effects and predictive validity Bates, J.A.
 1995
 37 9 p. 663-
1 p.
 artikel
194 Natural history and course of adult anxiety disorders Noyes Jr., R.
 1995
 37 9 p. 594-
1 p.
 artikel
195 Neural network simulations of schizophrenic performance in a variant of the CPT-AX Braver, T.S.
 1995
 37 9 p. 634-
1 p.
 artikel
196 Neurobiology of Tourette syndrome Singer, H.S.
 1995
 37 9 p. 629-
1 p.
 artikel
197 Neurobiology of Tourette syndrome Singer, H.S.
 1995
 37 9 p. 629-630
2 p.
 artikel
198 Neuroimaging correlates of genetic marker for schizophrenia Shihabuddin, L.
 1995
 37 9 p. 662-
1 p.
 artikel
199 Neuroleptic-induced motor abnormalities and cholinergic cell loss in rats Lohr, J.B.
 1995
 37 9 p. 627-
1 p.
 artikel
200 Neuroleptics, olfactory sensitivity and schizophrenia Sirota, P.
 1995
 37 9 p. 664-
1 p.
 artikel
201 Neurologic soft signs in neuroleptic naive patients with schizophrenia Chae, J.H.
 1995
 37 9 p. 662-663
2 p.
 artikel
202 Neuropsychological deficit and hypothetical risk for schizophrenia Burns, S.A.
 1995
 37 9 p. 636-
1 p.
 artikel
203 Neuropsychological deficits in first-episode and chronic schizophrenia Goldman, R.S.
 1995
 37 9 p. 676-
1 p.
 artikel
204 Neuropsychological function in deficit versus nondeficit schizophrenia Smet, I.C.
 1995
 37 9 p. 676-
1 p.
 artikel
205 New psychopharmacologic treatment strategies Glick, I.D.
 1995
 37 9 p. 646-
1 p.
 artikel
206 Nicotine addiction in chronic schizophrenic inpatients de Leon, J.
 1995
 37 9 p. 640-
1 p.
 artikel
207 Nighttime ACTH, cortisol, prolactin, and growth hormone secretion in prepubertal depression De Bellis, M.D.
 1995
 37 9 p. 594-
1 p.
 artikel
208 NMDA receptor hypofunction and schizophrenia Olney, J.W.
 1995
 37 9 p. 667-
1 p.
 artikel
209 Non-pathological associational loosening of Marlon Brando: A sign of hypoarousal? Alias, A.G.
 1995
 37 9 p. 613-
1 p.
 artikel
210 Nonsense change in the D5 dopamine receptor gene search for behavioral phenotypes Zald, D.H.
 1995
 37 9 p. 670-671
2 p.
 artikel
211 Odor identification and regional cerebral glucose metabolism in schizophrenia Harper Mozley, L.
 1995
 37 9 p. 654-
1 p.
 artikel
212 Ovarian steroids antagonize glucocorticoid effects on HPA axis Young, E.A.
 1995
 37 9 p. 623-
1 p.
 artikel
213 P300 amplitude tracks clinical status in schizophrenic patients Ford, J.M.
 1995
 37 9 p. 671-672
2 p.
 artikel
214 Panic attacks with psychotic features Galynker, I.
 1995
 37 9 p. 617-
1 p.
 artikel
215 PCP/MK-801-elicited “popping” and hyperactivity in mice Deutsch, S.I.
 1995
 37 9 p. 598-599
2 p.
 artikel
216 Pedantic speech and Asperger syndrome Ghaziuddin, M.
 1995
 37 9 p. 658-
1 p.
 artikel
217 Perinatal distress and bipolar affective disorder symptoms Wilcox, J.A.
 1995
 37 9 p. 603-604
2 p.
 artikel
218 Peripheral GABA levels in patients with premenstrual dysphoric disorder Yonkers, K.A.
 1995
 37 9 p. 607-
1 p.
 artikel
219 Peripheral indices of dopamine and serotonin in schizophrenia Evans, D.R.
 1995
 37 9 p. 679-
1 p.
 artikel
220 P50 ERP suppression (gating) and habituation deficits in schizophrenia Braff, D.L.
 1995
 37 9 p. 635-
1 p.
 artikel
221 Persistent sleep abnormalities in primary alcoholics with secondary depression Clark, C.P.
 1995
 37 9 p. 620-621
2 p.
 artikel
222 PET and behavioral responses to IV d-fenfluramine in humans Meyer, J.
 1995
 37 9 p. 600-
1 p.
 artikel
223 Pharmacological algorithms for treatment resistant depression in children and adolescents Alessi, N.
 1995
 37 9 p. 595-
1 p.
 artikel
224 31Phosphorous MRSI of the frontal lobes in bipolar disorder Deicken, R.F.
 1995
 37 9 p. 608-609
2 p.
 artikel
225 P300 in the differentiation of Alzheimer's disease and depression Bahro, M.
 1995
 37 9 p. 596-597
2 p.
 artikel
226 Plasma clozapine concentrations and clinical response in schizophrenia Tomori, O.
 1995
 37 9 p. 673-
1 p.
 artikel
227 Plasma cytokines, acute phase proteins and cortisol in major depression Kronfol, Z.
 1995
 37 9 p. 609-
1 p.
 artikel
228 Plasma GABA in children and adolescents with mood and behavior diorders Petty, F.
 1995
 37 9 p. 608-
1 p.
 artikel
229 Plasma GABA predicts response to divalproex in mania Petty, F.
 1995
 37 9 p. 601-
1 p.
 artikel
230 Plasma lipid peroxidation and HVA in first episode psychosis Scheffer, R.
 1995
 37 9 p. 681-
1 p.
 artikel
231 31P MRS study of clozapine vs haloperidol effects on brain metabolism Skinner, T.E.
 1995
 37 9 p. 648-
1 p.
 artikel
232 Postmortem study of DA, 5HT, and their metabolites in cortex of schizophrenics and controls Powchik, P.
 1995
 37 9 p. 635-
1 p.
 artikel
233 Predicting onset and course of adolescent depression with sleep and cortisol measures Rao, U.
 1995
 37 9 p. 595-
1 p.
 artikel
234 Prefrontal activation during the WCST in schizotypal personality Siegel Jr., B.V.
 1995
 37 9 p. 597-
1 p.
 artikel
235 Prefrontal subdivisions, temporal lobe, and schizophrenia: An MRI study Wible, C.G.
 1995
 37 9 p. 683-
1 p.
 artikel
236 Prepulse inhibition of startle-induced reductions of accumbens dopamine Geyer, M.A.
 1995
 37 9 p. 634-
1 p.
 artikel
237 Prepulse inhibitory deficits in schizophrenia: Gender effects Braff, D.L.
 1995
 37 9 p. 654-
1 p.
 artikel
238 Pretreatment plasma free MHPG levels as predictors of fluoxetine response Lu, R-B.
 1995
 37 9 p. 600-
1 p.
 artikel
239 Prevalence and correlates of apathy and irritability in Alzheimer's disease Migliorelli, R.
 1995
 37 9 p. 642-
1 p.
 artikel
240 Prevalence and correlates of catatonia in depressed patients Starkstein, S.E.
 1995
 37 9 p. 602-
1 p.
 artikel
241 Prevalence and correlates of extrapyramidalism in Alzheimer disease Starkstein, S.E.
 1995
 37 9 p. 596-
1 p.
 artikel
242 Prolonged haloperidol induces a chronic AP-1 complex in the striatum Rogue, P.
 1995
 37 9 p. 599-
1 p.
 artikel
243 P3 topography differs in schizophrenia-like and mania-like first episode psychosis Salisbury, D.F.
 1995
 37 9 p. 626-
1 p.
 artikel
244 Pursuit eye movement dysfunction in never-medicated schizophrenic patients Sweeney, J.
 1995
 37 9 p. 679-
1 p.
 artikel
245 Race and substance abuse in schizophrenia Lawson, W.B.
 1995
 37 9 p. 668-
1 p.
 artikel
246 Racial influence on diagnosis in psychotic mania Strakowski, S.M.
 1995
 37 9 p. 604-
1 p.
 artikel
247 Reading versus demographic-based estimates of premorbid intelligence in schizophrenia Tracy, J.I.
 1995
 37 9 p. 639-640
2 p.
 artikel
248 Reduced fertility in schizophrenia: Here to stay? Ward, S.
 1995
 37 9 p. 639-
1 p.
 artikel
249 Reduced heart rate variability in geriatric depression Menolascino, M.P.
 1995
 37 9 p. 605-
1 p.
 artikel
250 Reduced mesiotemporal lobe volumes and asymmetries in schizophrenia Szeszko, P.R.
 1995
 37 9 p. 671-
1 p.
 artikel
251 Regional brain activity during self-induced anger and anxiety Kimbrell, T.A.
 1995
 37 9 p. 617-618
2 p.
 artikel
252 Regional cerebral glucose metabolism during stroop task in paranoid schizophrenics Kraft, L.W.
 1995
 37 9 p. 680-
1 p.
 artikel
253 Regulation of CRF in BE (2)-M17 and BE (2)-C neuroblastoma cell lines Han, J.
 1995
 37 9 p. 647-
1 p.
 artikel
254 Relationship among clozapine level, EEG photic driving, and clinical symptoms Jin, Y.
 1995
 37 9 p. 669-
1 p.
 artikel
255 Relationship between frontal lobe and serotonergic function in OCD Wong, C.
 1995
 37 9 p. 615-
1 p.
 artikel
256 REM during naps in combat-related PTSD Mellman, T.A.
 1995
 37 9 p. 622-
1 p.
 artikel
257 Restriction fragment length polymorphisms in 5-HTT gene sequence Rausch, J.
 1995
 37 9 p. 623-
1 p.
 artikel
258 Risperidone in the treatment of children and adolescents with Tourette's disorder Mandoki, M.W.
 1995
 37 9 p. 618-
1 p.
 artikel
259 Risperidone treatment of children and adolescents with schizophrenic disorder Mandoki, M.W.
 1995
 37 9 p. 678-
1 p.
 artikel
260 Safety and efficacy of CI-988 in GAD Sramek, J.J.
 1995
 37 9 p. 623-
1 p.
 artikel
261 Safety and tolerance of ENA 713 in patients with Alzheimer's disease (AD) Cutler, N.R.
 1995
 37 9 p. 643-644
2 p.
 artikel
262 Schizophrenia, viruses, and genes Cowen, M.A.
 1995
 37 9 p. 662-
1 p.
 artikel
263 Schizophrenic deficits in processing context: A test of neural network simulations Cohen, J.D.
 1995
 37 9 p. 632-
1 p.
 artikel
264 Schizotypal disorder: Cognitive, behavioral, and neuropathological indicators Dickey, C.C.
 1995
 37 9 p. 597-
1 p.
 artikel
265 Seasonal variation of prolactin response to m-CPP challenge Grossman, R.
 1995
 37 9 p. 648-
1 p.
 artikel
266 Selective age-related reductions in frontal lobe function Hoptman, M.J.
 1995
 37 9 p. 670-
1 p.
 artikel
267 Selective attention in schizophrenics measured by a modified LaBerge task Moayeri, S.E.
 1995
 37 9 p. 669-
1 p.
 artikel
268 Selective deficits in visual perception and recognition in schizophrenia O'Donnell, B.F.
 1995
 37 9 p. 631-
1 p.
 artikel
269 Senile plaques in the locus coeruleus of young patients with depression Issidorides, M.R.
 1995
 37 9 p. 608-
1 p.
 artikel
270 Seroquel (ICI 204, 636): A novel, atypical antipsychotic Borison, R.L.
 1995
 37 9 p. 661-
1 p.
 artikel
271 Serotonergic responsivity in compulsive personality disorder Stein, D.J.
 1995
 37 9 p. 645-
1 p.
 artikel
272 Serotonin-induced increases in platelet cytosolic calcium concentration in depressed, schizophrenic, PTSD, and substance abuse patients Konopka, L.M.
 1995
 37 9 p. 619-620
2 p.
 artikel
273 Sex differences in the 3-factor model of schizophrenia Haas, G.
 1995
 37 9 p. 640-
1 p.
 artikel
274 Side effects profile of risperidone in the treatment of children and adolescents Mandoki, M.W.
 1995
 37 9 p. 651-
1 p.
 artikel
275 Single trial stroop versus stroop card measurements in schizophrenia Carter, C.
 1995
 37 9 p. 637-
1 p.
 artikel
276 Sleep disturbance and psychiatric disorders Breslau, N.
 1995
 37 9 p. 655-656
2 p.
 artikel
277 Sleep in acute and chronic PTSD Mellman, T.A.
 1995
 37 9 p. 617-
1 p.
 artikel
278 Smooth pursuit eye movements as an outcome measure in pharmacotherapy of schizophrenia Rosenberg, P.B.
 1995
 37 9 p. 666-667
2 p.
 artikel
279 Smooth-pursuit eye movements in childhood-onset schizophrenia Jacobsen, L.K.
 1995
 37 9 p. 625-
1 p.
 artikel
280 Spatial working memory pathology and negative symptoms in schizophrenia Carter, C.
 1995
 37 9 p. 637-638
2 p.
 artikel
281 SSRI dosages for Mexican-Americans Rodarte, S.
 1995
 37 9 p. 609-
1 p.
 artikel
282 Stability of the acoustic startle reflex: Amplitude vs area measures Light, G.A.
 1995
 37 9 p. 618-
1 p.
 artikel
283 State-trait aspects of polysomnographic abnormalities in schizophrenia Maixner, S.
 1995
 37 9 p. 675-676
2 p.
 artikel
284 Stroke or TBI as models of depressive disorder Robinson, R.G.
 1995
 37 9 p. 630-
1 p.
 artikel
285 Study of amino acid in CSF of schizophrenic patients Jin, W.D.
 1995
 37 9 p. 641-
1 p.
 artikel
286 Suicide among psychiatric hospital inpatients Roy, A.
 1995
 37 9 p. 601-
1 p.
 artikel
287 Superior temporal gyrus volume and asymmetry in first-episode schizophrenia Wu, H.
 1995
 37 9 p. 671-
1 p.
 artikel
288 Support for a neurodevelopmental view of schizophrenia Cornblatt, B.
 1995
 37 9 p. 670-
1 p.
 artikel
289 Symptom dimensions in schizophrenia: Stability and interpretation Woods, D.
 1995
 37 9 p. 673-
1 p.
 artikel
290 Tacrine reduces the secretion of beta-amyloid precursor protein in cell lines Lahiri, D.K.
 1995
 37 9 p. 643-
1 p.
 artikel
291 Tc-99m HMPAO brain SPECT in stroke patients with negative symptoms Galynker, I.
 1995
 37 9 p. 673-
1 p.
 artikel
292 Tc99m HMPAO brain SPECT with visuospatial and verbal activation in normal subjects Galynker, I.
 1995
 37 9 p. 672-
1 p.
 artikel
293 The anterior cingulate glucose metabolic rate in schizophrenia Haznedar, M.M.
 1995
 37 9 p. 636-637
2 p.
 artikel
294 The comparative efficacy of antipsychotic drugs: A meta-analysis Davis, J.M.
 1995
 37 9 p. 651-
1 p.
 artikel
295 The difference in change of plasma cortisol after dexamethasone suppression test between positive and negative schizophrenics Jin, W.D.
 1995
 37 9 p. 641-
1 p.
 artikel
296 The DST as a predictor of outcome in depression Johnson, G.
 1995
 37 9 p. 606-
1 p.
 artikel
297 The effect of nortriptyline on verbal recall Pomara, N.
 1995
 37 9 p. 611-
1 p.
 artikel
298 The effect of state on auditory P50 gating in schizophrenics and normals Griffith, J.M.
 1995
 37 9 p. 682-
1 p.
 artikel
299 The effects of Seroquel (ICI 204.636) on plasma prolactin in patients with schizophrenia Hamner, M.B.
 1995
 37 9 p. 683-
1 p.
 artikel
300 The frequency of remission, relapse and recurrence in children and adolescents with MDD Emslie, G.
 1995
 37 9 p. 594-
1 p.
 artikel
301 The functional neuroanatomy of bimodal hallucinations in a drug-naive schizophrenic Silbersweig, D.
 1995
 37 9 p. 631-
1 p.
 artikel
302 The lower limits of the plasma dexamethasone window in Chinese depressives Shiah, I-S.
 1995
 37 9 p. 655-
1 p.
 artikel
303 Theophylline effects on older normal volunteers Cantillon, M.
 1995
 37 9 p. 647-
1 p.
 artikel
304 The progesterone antagonist RU-486 effect in menstrually related dysphoria Halbreich, U.
 1995
 37 9 p. 659-
1 p.
 artikel
305 The psychopathology of Huntington's disease Folstein, S.
 1995
 37 9 p. 630-
1 p.
 artikel
306 The relationship of treatment response to chronicity of illness in schizophrenia Szymanski, S.
 1995
 37 9 p. 661-
1 p.
 artikel
307 The stability and interrelationships of CPT-AX and stroop performance in schizophrenia Barch, D.M.
 1995
 37 9 p. 634-
1 p.
 artikel
308 Thyroid function during depression and after symptomatic recovery Duval, F.
 1995
 37 9 p. 601-
1 p.
 artikel
309 Timecourse of antidepressant effect of electroconvulsive therapy Maixner, D.
 1995
 37 9 p. 624-
1 p.
 artikel
310 Tolerability and pharmacodynamics of besipirdine in Alzheimer's disease Cutler, N.R.
 1995
 37 9 p. 643-
1 p.
 artikel
311 Topographic change in EEG photic driving following clozapine Jin, Y.
 1995
 37 9 p. 669-670
2 p.
 artikel
312 Top ranked boxers are less hirsute than lower level boxers: An example for the importance of 5α-reductase? Alias, A.G.
 1995
 37 9 p. 612-613
2 p.
 artikel
313 Treatment and follow-up of children with anxiety disorders Klein, R.G.
 1995
 37 9 p. 593-
1 p.
 artikel
314 Triazolam and diphenhydramine effects on ECT Guthrie, S.K.
 1995
 37 9 p. 645-646
2 p.
 artikel
315 Tryptophan hydroxylase polymorphism is associated with impulsive aggression Yovell, Y.
 1995
 37 9 p. 644-
1 p.
 artikel
316 T3 suppression test: A better way of assessing HPT axis disregulation in depression? Mourilhe, P.
 1995
 37 9 p. 613-
1 p.
 artikel
317 Ultra and very low frequency heart rate variability in panic disorder: Analysis of Holter records Sobolewski, E.
 1995
 37 9 p. 614-
1 p.
 artikel
318 Urinary catecholamine excretion in hyperactive and normal boys Hanna, G.L.
 1995
 37 9 p. 644-
1 p.
 artikel
319 Validity studies in functional magnetic resonance imaging: Application to schizophrenia Forman, S.D.
 1995
 37 9 p. 633-634
2 p.
 artikel
320 VBR and premorbid status in schizophrenia DeQuardo, J.R.
 1995
 37 9 p. 675-
1 p.
 artikel
321 VBR in schizophrenia: Relationship to family history and season of birth DeQuardo, J.R.
 1995
 37 9 p. 674-
1 p.
 artikel
322 Visual search mechanisms in schizophrenia Blumberg, H.
 1995
 37 9 p. 664-
1 p.
 artikel
323 Vulnerability to ECT-induced seizures: The role of psychosis Waziri, R.
 1995
 37 9 p. 660-
1 p.
 artikel
324 Wisconsin card sorting in the young adult offspring of schizophrenics Wolf, L.E.
 1995
 37 9 p. 632-
1 p.
 artikel
                             324 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland